Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Clinical · Molecular biology

Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma

Summary

This study evaluated the utility of RNA sequencing and immunohistochemistry (IHC) for detecting NTRK fusions in thyroid carcinoma, particularly those potentially missed by gene panel testing. Two patient groups were analyzed: advanced thyroid cancer cases undergoing panel testing and surgical papillary thyroid carcinoma cases screened by IHC. Results indicated that a gene panel test missed one SQSTM1-NTRK3 fusion, while pan-TRK IHC showed variable sensitivity depending on the fusion type. The study concludes that active screening for NTRK fusions is desirable, especially in patients without MAPK pathway abnormalities or with positive pan-TRK staining.

Critical appraisal

Clinical. This study has immediate clinical implications for managing advanced thyroid carcinoma patients, highlighting that standard gene panel tests may miss NTRK fusions, which are therapeutic targets for TRK inhibitors. The missed detection of an SQSTM1-NTRK3 fusion by a gene panel suggests that clinicians should consider complementary screening methods, such as pan-TRK IHC followed by RNA sequencing, particularly in patients without known MAPK pathway alterations. This approach could identify patients eligible for targeted therapies, potentially within 1-3 years if these methods are integrated into testing algorithms.

Molecular biology. From a molecular perspective, the study demonstrates the superiority of RNA sequencing over DNA-based gene panels for detecting certain NTRK fusions, such as the SQSTM1-NTRK3 fusion. It also evaluates pan-TRK IHC as a screening tool, noting variable sensitivity: strong for NTRK1, weak for NTRK3, and even absent for some ETV6-NTRK3 fusions. This underscores the importance of understanding the analytical limitations of each method and validates RNA sequencing as a robust technology for fusion detection, complementing or replacing panels in certain clinical scenarios.

The summary and the appraisal were written by a language model from the title and abstract of the original article. A curator decided to publish it. Methodology